Navigation Links
Aurobindo Gets USFDA Approval for Didanosine Chewable Tablets

Aurobindo Pharma Ltd today said it has received tentative approval by USFDA for its anti-HIV drug, Didanosine chewable tablets of 100mg, 150mg and 200mg strengths. //

This is the first generic version approval for Didanosine chewable in the world given by USFDA, Aurobindo Pharma informed the Bombay Stock Exchange.

The aforesaid product would now be available for purchase under the President's Emergency Plan for AIDS Relief (PEPFAR), it added.

The company manufactures both Active Pharmaceutical Ingredients (API) and formulation for this generic version and with this approval, the antiretroviral (ARV) product portfolio of the company increased to 17.

Didanosine is a Nucleoside reverse transcriptase inhibitor (NRTI) class of drugs, and a key component of the ARV regimens in various parts of the world. This molecule enjoys approximately USD 100 mio of market share, it said.

The drug helps prevent AIDS virus from reproducing. It is used in combination with other antiretroviral agents for the treatment of HIV-1 infection. It is the version of VIDEX an anti-HIV medication manufactured by Bristol Myers Squibb.

The shares of the company was trading at Rs 608, up 2.16 per cent at the BSE.

Source:PTI News
'"/>




Page: 1

Related medicine news :

1. Aurobindo gets U.S. FDA approval for Cephalexin
2. US FDA approved Aurobindo Pharma to produce generic AIDS drug
3. Aurobindo Receives Approval from USFDA for anti-AIDS drug
4. Aurobindo Gets Tentative USFDA Approval For Its HIV-1 Drug
5. Aurobindo Pharma Purchases US Manufacturing Facility
6. Aurobindo Gets USFDA Approval for A 3-Drug Combination Pack
7. Morepan to file new drug applications with the USFDA
8. Ranbaxy Gets USFDA Approval For Doxycycline Tablets
9. Cadila Gets Tentative USFDA Nod For Pravastatin Sodium Tablets
10. Lupin Gets USFDA Approval For Quinapril Tablets
11. Ranbaxy Gets USFDA Nod For Simvastatin
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/22/2017)... Tampa, Fla. (PRWEB) , ... February 22, 2017 ... ... the field of regenerative medicine in recent years. The technology is so cutting ... sanction regulations on the protocol for stem cell procedures. However, successful patient outcomes ...
(Date:2/22/2017)... ... 2017 , ... Giving patients with diabetes customized coaching sessions, ... hospital admissions, and better blood pressure and glycemic control, a new study ... be found here . , The study comes as health plans increasingly ...
(Date:2/22/2017)... ... February 22, 2017 , ... Sideline Products participated in the World Horse ... host Tom Seay and his production crew. Tom Seay’s program “Best of America ... world. Saddle Sidekicks will be featured on April 6, 2017. After the broadcast, ...
(Date:2/22/2017)... ... February 22, 2017 , ... The ... Insights to help small practices in Delaware, New Jersey, Pennsylvania and West Virginia ... Medicare Access and CHIP Reauthorization Act of 2015 (MACRA). , This technical ...
(Date:2/22/2017)... ... February 22, 2017 , ... Forty-five percent of ... report that family members or friends have also commented about their poor hearing. ... wear hearing aids. One reason, suggested by 89 percent of American respondents, is ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... 2017 Orthopedic and cardiac devices will ... demographic patterns lead to an increasing prevalence of ... exercise-related injuries, chronic back problems, heart valve replacement, ... The future of medical implants faces many uncertainties. ... and more: - What types of medical ...
(Date:2/23/2017)... -- CTI BioPharma Corp. (CTI BioPharma) (NASDAQ and MTA: CTIC) ... quarter and full year 2016 financial results on Thursday, March ... markets. Following the announcement, members of the management team ... results and provide a general corporate update at 4:30 p.m. ... obtained as follows: Thursday, March 2 1:30 ...
(Date:2/22/2017)... VIEW, Calif. , Feb. 22, 2017 ... that it will release financial results for the fourth ... Wednesday, March 8, 2017.  The Company,s management team will ... PT / 5:00 p.m. ET. Investors interested ... by dialing (844) 707-0665 for domestic callers or (703) ...
Breaking Medicine Technology: